The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $98.54

Today's change-1.01 -1.01%
Updated September 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $98.54

Today's change-1.01 -1.01%
Updated September 29 4:02 PM EDT. Delayed by at least 15 minutes.

Varian Medical Systems Inc down (U.S.)$1.01

Varian Medical Systems Inc closed lower Thursday, dropping (U.S.)$1.01 or 1.01% to (U.S.)$98.54. Over the last five days, shares are unchanged, but are currently 1.12% below its 52-week high. This security has outperformed the S&P 500 by 20.35% during the last year.

Key company metrics

  • Open(U.S.) $99.41
  • Previous close(U.S.) $99.55
  • High(U.S.) $99.49
  • Low(U.S.) $97.85
  • Bid / Ask-- / --
  • YTD % change+21.96%
  • Volume706,527
  • Average volume (10-day)560,542
  • Average volume (1-month)626,866
  • Average volume (3-month)685,695
  • 52-week range(U.S.) $71.38 to (U.S.) $99.66
  • Beta0.71
  • Trailing P/E24.95×
  • P/E 1 year forward21.40×
  • Forward PEG1.89×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.95
Updated September 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.30%

Based on its net profit margin of 12.30%, Varian Medical Systems Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.16%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 01, 201607/01/2016Apr 01, 201604/01/2016Jan 01, 201601/01/2016Oct 02, 201510/02/2015
Revenue789759757818
Total other revenue--------
Total revenue789759757818
Gross profit346317310318
Total cost of revenue443442447500
Total operating expense659625640689
Selling / general / administrative151121133148
Research & development65626069
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income130134117129
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax132135118131
Income after tax99978999
Income tax, total33382932
Net income99978999
Total adjustments to net income--------
Net income before extra. items99978999
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items99978999
Inc. avail. to common incl. extra. items99978999
Diluted net income99978999
Dilution adjustment0--0--
Diluted weighted average shares95969899
Diluted EPS excluding extraordinary itemsvalue per share1.041.010.911.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.041.010.911.00